KO Stock Analysis: The Coca-Cola | NYSE
Beverages - Non-Alcoholic | NYSE, USA | Market Cap: 376.129m USD | 12M Return: 31.6% | US1912161007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.31B
EPS Trend: 98.2%
Qual. Beats: 5
Rev. Trend: 95.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Coca-Cola Company (NYSE: KO) is a global nonalcoholic beverage manufacturer founded in 1886 and headquartered in Atlanta, Georgia. It produces and sells a broad portfolio of drinks including sparkling soft drinks, water, sports drinks, coffee, tea, juices, value-added dairy, plant-based beverages, and emerging beverage categories. Its brand portfolio spans flagship labels such as Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Sprite, and Fanta, alongside water brands like Dasani, smartwater, and Topo Chico, as well as coffee, juice, and dairy offerings including Costa, Minute Maid, and fairlife.
In addition to finished beverages, the company sells beverage concentrates, syrups, and fountain syrups to retailers such as restaurants and convenience stores. Distribution is handled through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as company-operated bottling and distribution assets.
The company operates within the Consumer Staples sector and is classified in the Soft Drinks & Non-alcoholic Beverages sub-industry. Its business model is anchored by the traditional concentrate-based system, in which Coca-Cola manufactures and sells syrups and concentrates to bottling partners that handle packaging, distribution, and local market execution-an asset-light structure that supports global scale while limiting direct capital exposure to bottling operations.
- Emerging markets revenue lifts results amid developed market softness
- Pricing actions offset NARTY concentrate volume declines
- fairlife and BODYARMOR accelerate premium portfolio growth
| Net Income: 14.3b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 13.94 > 1.0 |
| NWC/Revenue: 15.31% < 20% (prev 9.91%; Δ 5.40% < -1%) |
| CFO/TA 0.15 > 3% & CFO 16.3b > Net Income 14.3b |
| Net Debt (28.5b) to EBITDA (19.8b): 1.44 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.31b) vs 12m ago -0.02% < -2% |
| Gross Margin: 61.89% > 18% (prev 61.43%; Δ 0.46% > 0.5%) |
| Asset Turnover: 47.23% > 50% (prev 45.11%; Δ 2.13% > 0%) |
| Interest Coverage Ratio: 12.00 > 6 (EBIT TTM 18.8b / Interest Expense TTM 1.57b) |
| A: 0.07 (Total Current Assets 32.9b - Total Current Liabilities 25.2b) / Total Assets 108b |
| B: 0.78 (Retained Earnings 84.2b / Total Assets 108b) |
| C: 0.18 (EBIT TTM 18.8b / Avg Total Assets 106b) |
| D: 0.52 (Book Value of Equity 36.1b / Total Liabilities 69.6b) |
| Altman-Z'' = 4.74 = AA |
| DSRI: 0.84 (Receivables 3.73b/4.17b, Revenue 50.1b/47.1b) |
| GMI: 0.99 (GM 61.43% / 61.89%) |
| AQI: 0.94 (AQ_t 0.61 / AQ_t-1 0.64) |
| SGI: 1.07 (Revenue 50.1b / 47.1b) |
| TATA: -0.02 (NI 14.3b - CFO 16.3b) / TA 108b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of August 21, 2026, the stock is trading at USD 90.50 with a total of 14,921,645 shares traded. Over the past week, the price has changed by +3.52%, over one month by +10.20%, over three months by +11.69% and over the past year by +31.63%.
Current recommended Stop Loss: 88.40 (which is 2.3% or 1.3 ATR below the current price).
The Coca-Cola has received a consensus analysts rating of 4.35. Therefore, it is recommended to buy KO.
- StrongBuy: 14
- Buy: 8
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 94.7 | 4.6% |
P/E Trailing = 26.2523
P/E Forward = 26.3158
P/S = 7.5032
P/B = 10.3392
P/EG = 4.1851
Revenue TTM = 50.1b USD
EBIT TTM = 18.8b USD
EBITDA TTM = 19.8b USD
Long Term Debt = 37.0b USD (from longTermDebt, last quarter)
Short Term Debt = 6.54b USD (from shortTermDebt, last quarter)
Debt = 44.9b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 28.5b USD (calculated: Debt 44.9b - CCE 16.4b)
Enterprise Value = 405b USD (376b + Debt 44.9b - CCE 16.4b)
Interest Coverage Ratio = 12.00 (Ebit TTM 18.8b / Interest Expense TTM 1.57b)
EV/FCF = 28.30x (Enterprise Value 405b / FCF TTM 14.3b)
FCF Yield = 3.53% (FCF TTM 14.3b / Enterprise Value 405b)
FCF Margin = 28.52% (FCF TTM 14.3b / Revenue TTM 50.1b)
Net Margin = 28.56% (Net Income TTM 14.3b / Revenue TTM 50.1b)
Gross Margin = 61.89% ((Revenue TTM 50.1b - Cost of Revenue TTM 19.1b) / Revenue TTM)
Gross Margin QoQ = 62.89% (prev 62.96%)
Tobins Q-Ratio = 3.75 (Enterprise Value 405b / Total Assets 108b)
Interest Expense / Debt = 3.49% (Interest Expense 1.57b / Debt 44.9b)
Taxrate = 16.41% (2.83b / 17.2b)
NOPAT = 15.7b (EBIT 18.8b * (1 - 16.41%))
Current Ratio = 1.30 (Total Current Assets 32.9b / Total Current Liabilities 25.2b)
Debt / Equity = 1.24 (Debt 44.9b / totalStockholderEquity, last quarter 36.1b)
Debt / EBITDA = 1.44 (Net Debt 28.5b / EBITDA 19.8b)
Debt / FCF = 1.99 (Net Debt 28.5b / FCF TTM 14.3b)
Total Stockholder Equity = 33.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.49% (Net Income 14.3b / Total Assets 108b)
RoE = 42.99% (Net Income TTM 14.3b / Total Stockholder Equity 33.3b)
RoCE = 26.74% (EBIT 18.8b / Capital Employed (Equity 33.3b + L.T.Debt 37.0b))
RoIC = 18.11% (NOPAT 15.7b / Invested Capital 86.8b)
WACC = 4.49% (E(376b)/V(421b) * Re(4.68%) + D(44.9b)/V(421b) * Rd(3.49%) * (1-Tc(0.16)))
Discount Rate = 4.68% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -83.23 | Cagr: -0.09%
[DCF] Terminal Value 75.44% ; FCFF base≈14.3b ; Y1≈14.4b ; Y5≈15.2b
[DCF] Fair Price = 48.35 (EV 237b - Net Debt 28.5b = Equity 208b / Shares 4.30b; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 98.19 | EPS CAGR: 6.68% | SUE: 4.0 | # QB: 5
Revenue Correlation: 95.08 | Revenue CAGR: 3.26% | SUE: 0.54 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.88 | Chg30d=+0.08% | Revisions=+6% | Analysts=18
EPS current Year (2026-12-31): EPS=3.30 | Chg30d=+1.04% | Revisions=+88% | GrowthEPS=+10.1% | GrowthRev=+3.5%
EPS next Year (2027-12-31): EPS=3.53 | Chg30d=+1.23% | Revisions=+79% | GrowthEPS=+6.8% | GrowthRev=+0.2%
[Analyst] Revisions Ratio: +71% (up=48, down=7)